The Transplant Diagnostics Market is anticipated to grow at a rate of 7.04% during the forecast period 2021 to 2028 and is projected to grow at USD 672.50 million till 2028. Transplantation is one of the most preferred treatment options given to the patients suffering from chronic dialysis therapy. It is the most workable option in conditions associated with bone marrow, heart and liver. Due to the technological development, a number of transplant procedures are performed in the multispecialty hospitals due to the increasing funding offered by private collaborations and government. In order to analyze the level of infection inside an organ, the diagnosis in transplants is performed at the end of donor and patient. There are a few restraints of the transplant diagnostics market such as high price of transplants, reimbursement policies, ethical and social problems connected to organ transplants and irregular insurance. There is much improvement is diagnostic process crucially with companies dedicated to developing antibody monitoring, software, HLA typing technologies and instrument. It is regularly being utilized for diagnostics during transplantation around various body organs. The transplant diagnostics is essential to evaluate various aspects liked with a transplant while performing pre and post transplantation. One of the primary factors driving the growth of the transplant diagnostics market is the increase in the number of organ transplants performed around the world. The disparity between organ demand and availability, which is always greater than supply, accelerates the expansion of the transplant diagnostics market. The transplant diagnostics market is also influenced by an increased preference for preventative care testing, public awareness regarding organ donation and transplantation, and an increase in the incidences of infectious illnesses such as COVID-19. Furthermore, improvements to healthcare facilities, favourable government efforts, an increase in public-private funding for targeted research activities, improved healthcare infrastructure, and an increase in healthcare expenditure all have a beneficial impact on the transplant diagnostics industry. Furthermore, during the forecast period of 2021 to 2028, technological developments and an increase in the adoption of cross-matching and chimerism testing during pre- and post-transplantation would provide lucrative opportunities for transplant diagnostics market participants.